Results 161 to 170 of about 17,930 (241)

When rehabilitation is not enough, how targeting metabolism can overcome the limited plasticity of skeletal muscle after traumatic injury

Experimental Physiology, EarlyView.
Abstract There is a category of large‐scale neuromusculoskeletal injuries that result in long‐term functional disabilities, and one such injury is volumetric muscle loss (VML) injury. In addition to the clinical outcomes related to long‐term dysfunction, co‐morbidities and reduced mobility and physical activity, this review addresses several ...
Sarah M. Greising, Jarrod A. Call
wiley   +1 more source

Maximizing blood pressure lowering effects: a review of drug class comparisons and rationale for combination approaches. [PDF]

Front Cardiovasc Med
Yang Y, Wan F, Xu J, Mei Deng H, Pan P.
europepmc   +1 more source

Absolute configuration of glycerol derivatives. 7. Enantiomers of 2-[[[2-(2,6-dimethoxyphenoxy)ethyl]amino]ethyl]-1,4-benzodioxane (WB-4101), a potent competitive .alpha.-adrenergic antagonist

, 1979
Wendel L. Nelson, Mark L. Powell, Donald C. Dyer   +2 more
openalex   +1 more source

Treatment of Post-Traumatic Stress Disorders with the Alpha-1 Adrenergic Antagonist Prazosin [PDF]

, 2016
P Simon, Pierre‐François Rousseau
openalex   +1 more source

Impaired nitric oxide‐dependent endothelial function in young male individuals with obesity before the onset of symptoms and complications

Experimental Physiology, EarlyView.
Abstract Endothelial dysfunction drives obesity‐related complications. Doppler ultrasound measurement of blood flow during 1‐min passive leg movements (PLM) is a valuable non‐invasive tool for assessing endothelial function and nitric oxide (NO)‐mediated vasodilation.
Lucrezia Zuccarelli, Giovanni Baldassarre, Adele Bondesan, Diana Caroli, Roberta De Micheli, Gabriella Tringali, Thomas Favaretto, Joanna Suraj‐Prazmowska, Anna Kurpinska, Joanna Majerczak, Stefan Chlopicki, Jerzy A. Zoladz, Alessandro Sartorio, Bruno Grassi   +13 more
wiley   +1 more source

Beta adrenergic signaling as a therapeutic target for autoimmunity. [PDF]

J Neuroimmunol
Lauten TH, Reed EC, Natour T, Pitts LJ, Jojo CN, Griffin BL, Case AJ.   +6 more
europepmc   +1 more source

A Pilot Trial of the Alpha‐1 Adrenergic Antagonist, Prazosin, for Alcohol Dependence [PDF]

, 2009
Tracy L. Simpson, Andrew J. Saxon, Charles Meredith, Carol A. Malte, Brittney McBride, Laura Ferguson, Christopher Gross, Kim Hart, Murray A. Raskind   +8 more
openalex   +1 more source

Acute systemic and energy metabolism responses to velocity‐based resistance training following an oral glucose load in individuals with excess body weight

Experimental Physiology, EarlyView.
Abstract We investigated the acute metabolic effects of two velocity‐based resistance training (RT) protocols, differing in intra‐set velocity loss (VL) thresholds, on postprandial substrate oxidation and glycaemic responses following a 75 g oral glucose tolerance test in individuals with excess body weight.
Hugo Alejandro Carrillo‐Arango, Miguel Alejandro Atencio‐Osorio, Leidy Tatiana Ordoñez‐Mora, Baisuli Benitez‐Gómez, Robinson Ramírez‐Vélez, Mikel Izquierdo   +5 more
wiley   +1 more source

Pharmacotherapy Risks in Rare Genetic Diseases: Cross-Referencing ACMG Secondary Findings v3.2 List With Clinical Databases. [PDF]

Clin Transl Sci
Allen JD, Duong BQ, Brady J, Arn P.
europepmc   +1 more source

Pilot Results from a Randomized Trial in Men Comparing Alpha-Adrenergic Antagonist versus Behavior and Exercise for Nocturia and Sleep [PDF]

, 2016
Theodore M. Johnson, Camille P. Vaughan, Patricia S. Goode, Donald L. Bliwise, Alayne D. Markland, Carrie Huisingh, David T. Redden, Gerald McGwin, Rina Eisenstein, Joseph G. Ouslander, Muta M. Issa, Kathryn L. Burgio   +11 more
openalex   +1 more source